ArticleCancers2022

Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells.

Yong Weon Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.